MINNEAPOLIS - Inspire Medical Systems, Inc. (NYSE:INSP) reported fourth quarter earnings that beat analyst expectations, but shares tumbled 8.7% as the company disclosed a coding clarification that ...
Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibilityFourth quarter revenue growth of 12% and full ...
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.2% year on year to $269.1 million. On the other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results